2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
Upcoming Webinar
An Innovative Therapy for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
Date: June 3, 2025 | 2:00 PM
AVMAPKI FAKZYNJA CO-PACK
An Innovative Therapy for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
KRAS-mutated low-grade serous ovarian cancer (LGSOC) involves distinct clinical considerations and limited established treatment options. As new therapies emerge, understanding their mechanisms, supporting evidence, and clinical application is essential for informed care.
Featured Speaker:
Sarah Hayward, PharmD, BCOP
Stephenson Cancer Center at OU Health
What’s We’ll Discuss:
- The clinical profile and treatment landscape of KRAS-mutated LGSOC
- Dual MEK and FAK inhibition: rationale and mechanism of action
- Key efficacy and safety data from the RAMP-201 trial
- Practical guidance on dosing, monitoring, and potential drug interactions
- Patient selection and real-world decision-making
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Additional Upcoming Webinars
Upcoming Webinar
BRAF V600E NSCLC: Updated Evidence for Encorafenib + Binimetinib
December 15, 2025 | 5:00 PM
December 16, 2025 | 2:00 PM
